Cronin has worked at Moderna since 2021, when she was brought on to market the biotech company’s COVID-19 vaccine.
Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...
CAMBRIDGE — As hundreds of employees gathered in the sweltering heat Wednesday outside Moderna’s new six-floor headquarters in Kendall Square, its chief executive said consolidating dispersed ...
CAMBRIDGE, MA / ACCESS Newswire / February 25, 2025 / Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: TD Cowen 45th Annual Health ...
Moderna, Inc. engages in the development of ... Chien in 2010 and is headquartered in Cambridge, MA.
Hosted on MSN2mon
Moderna extends gains as EU offers COVID vaccine contractFollowing four straight sessions of gains, Moderna (NASDAQ ... 17 European countries will have access to the Cambridge, MA-based biotech's messenger RNA-based shot for up to four years.
mRESVIA ® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback